Unlocking the Potential of AI in Accelerated Drug Discovery
Artificial intelligence (AI) is reshaping the pharmaceutical and biotech industries, offering unprecedented opportunities to accelerate drug discovery. By leveraging AI-driven approaches, companies can enhance biologics development, optimize de novo drug generation, and overcome traditional limitations in drug discovery. However, despite the promise, AI adoption in this space is not without challenges. Understanding both the opportunities […]